AF
TNYA icon

Amalgamated Financial’s Tenaya Therapeutics TNYA Stock Holding History

Amalgamated Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$29K Buy
+2,473
New +$29.9K ﹤0.01% 2640

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Amalgamated Financial's TNYA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Tenaya Therapeutics (TNYA) in Q1 2022: 2,473 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #2640 among its holdings.

50 funds tracked by Wall St. Rank hold TNYA as of Q1 2022.

  • Amalgamated Financial held 2,473 shares of Tenaya Therapeutics worth $29K as of Q1 2022.
  • Tenaya Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Tenaya Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2640 holding.
  • 50 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.